Epidemiology
Etiology
- Obesity (BMI > 30 kg/m²).
- Increased neck circumference (>17 inches in M; >16 inches in F).
- Anatomic narrowing: Tonsillar/adenoid hypertrophy (most common cause in peds), macroglossia (Down syndrome, acromegaly), micrognathia/retrognathia.
- Systemic dz: Hypothyroidism.
- Demographics: Older age, male sex.
Pathophysiology
- Obstruction of the upper airways → apnea → ↓ partial pressure of oxygen in arterial blood (PaO2), ↑ partial pressure of carbon dioxide in arterial blood (PaCO2, also known as hypercapnia), which leads to:
- ↑ Hypoxic pulmonary vasoconstriction → ↑ pulmonary hypertension → cor pulmonale
- ↑ Sympathetic activity → secondary hypertension c
- Respiratory acidosis → renal compensation → increased HCO3− retention and decreased chloride reabsorption
Clinical features
- History:
- Daytime somnolence (excessive daytime sleepiness). c
- Witnessed apneas/gasping/choking episodes during sleep, loud snoring.
- Morning headaches (due to nocturnal hypercapnia/vasodilation), unrefreshing sleep.
- Cognitive dysfunction, irritability, nocturia.
- Physical Examination:
- Neck circumference >17 inches (men) or >16 inches (women).
- High Mallampati score (III or IV).
- Systemic HTN (frequently resistant to multiple agents).
- Pulmonary hypertension and cor pulmonale
- edema
Diagnostics
Tip
In OSA, hypercapnia is usually absent when the patient is awake. This fact explains why arterial blood gases would be mostly normal in a patient with OSA. Therefore, this test is not useful for diagnosis.
- Initial/Screening: STOP-BANG questionnaire, Epworth Sleepiness Scale.
- Confirmatory/Gold Standard: In-lab Polysomnography (PSG). c
- Diagnostic Criteria: Apnea-Hypopnea Index (AHI) ≥ 15 events/hr, OR AHI ≥ 5 events/hr with associated symptoms (daytime sleepiness, waking gasping) or comorbidities (HTN, CAD).
- Alternative: Home Sleep Apnea Testing (HSAT) if high pre-test probability and no significant cardiopulmonary comorbidities.
- Key Labs: CBC showing secondary erythrocytosis (due to chronic nocturnal hypoxemia), TSH (to rule out hypothyroidism).
Treatment
- First-Line:
- Continuous Positive Airway Pressure (CPAP): Most effective treatment. Acts as a pneumatic splint to maintain airway patency.
- Lifestyle Modifications: Weight loss (most effective non-device intervention), avoidance of alcohol/sedatives, positional therapy (avoiding supine position).
- Second-Line/Alternative:
- Oral appliances: Mandibular advancement devices for mild-to-moderate OSA or patients intolerant of CPAP.
- Surgery: Uvulopalatopharyngoplasty (UPPP) or hypoglossal nerve stimulation in select cases.
Upper airway modification
- Description: surgical dilatation of the upper airway or neurostimulation of upper airway muscles
- Procedures
- Uvulopalatopharyngoplasty: resection of the uvula and redundant retrolingual, soft palate, and tonsillar tissue
- Other procedures include hypoglossal nerve stimulation, radiofrequency ablation of tongue and/or soft palate tissue, and palatal implants.